Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HE-69 vs cyclophosphamide in lupus nephritis
CTR20140614Phase 3Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mizoribine in lupus nephritis (LN), sponsored by Asahi Kasei Corporation. Started Oct 2014; status: completed.
02
Drugs
mizoribine
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on CTR20140614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140614.